Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Revance Therapeutics, Inc. (RVNC)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenues:  
    Service    4.52.92.41.71.41.3
    Product    102.494.887.776.561.946.1
    Other     1.7    
Total revenues    108.699.389.877.863.047.1
            Revenue growth   [+]  72.4%111.0%214.2%407.7%1371.2%9467.3%
Cost of goods sold   [+]  219.1204.9288.2366.5367.1354.4
Gross profit    -110.5-105.6-198.4-288.7-304.1-307.4
            Gross margin    -101.8%-106.3%-221.1%-371.0%-482.8%-653.0%
Selling, general and administrative   [+]  205.1192.1194.9198.8205.2200.6
Research and development    111.2115.2119.7116.3116.6115.6
Other operating expenses    -175.4  -329.1-334.8-328.1
EBITDA   [+]  -236.3-231.8-245.9-254.8-272.3-278.1
            EBITDA margin    -217.6%-233.4%-273.9%-327.5%-432.3%-590.7%
Depreciation    4.64.38.53.82.93.2
EBITA    -240.9-236.2-254.4-258.7-275.2-281.2
            EBITA margin    -221.9%-237.8%-283.4%-332.5%-437.0%-597.5%
Amortization of intangibles    18.218.2 16.015.814.2
EBIT   [+]  -259.2-254.4-266.9-274.7-291.0-295.4
            EBIT margin    -238.6%-256.1%-297.3%-353.1%-462.1%-627.7%
Interest expense, net   [+]  12.48.16.35.97.49.8
Other income (expense), net   [+]  -2.1-0.8-0.8-0.7-0.9-1.0
Pre-tax income    -273.6-263.3-274.0-281.3-299.3-306.2
Income taxes    -0.70.00.00.0-0.2-0.2
            Tax rate    0.3%0.0%0.0%0.0%0.1%0.1%
Net income    -273.6-263.3-274.0-281.3-296.5-303.4
            Net margin    -251.9%-265.0%-305.3%-361.6%-470.8%-644.6%
   
Basic EPS   [+]  ($3.93)($3.85)($4.04)($4.18)($4.56)($4.80)
Diluted EPS   [+]  ($3.93)($3.85)($4.04)($4.18)($4.56)($4.80)
   
Shares outstanding (basic)   [+]  69.568.467.867.365.063.2
Shares outstanding (diluted)   [+]  69.568.467.867.365.063.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy